Related Experiment Video
Updated: Aug 26, 2026
11:04
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
Preserving vision with verteporfin photodynamic therapy
1Wolverhampton Eye Infirmary, Wolverhampton, WV3 9QR.
Hospital Medicine (London, England : 1998)
|February 18, 2004
Abstract:
Wet age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population. Verteporfin photodynamic therapy (PDT) is significantly effective in preventing visual loss in patients with subfoveal choroidal neovascularization caused by exudative AMD. This article reviews verteporfin PDT and discusses treatment and evolving appraisal guidance.